Skip to content
Trained Market Monkey
Contact
Monkey Business
Tag:
investment thesis
Apr 14
When the Cure Costs Less Than the Stock: Inside Rocket Pharma’s Head-Scratching Approval Paradox
Apr 14
The Gene Therapy Gamble: Why Rocket Just Got FDA Approval But Lost the Market’s Attention
Apr 14
The Redmond Giant’s Discount Window: Why Maurice Just Caught Falling Knives (And Lived to Tell About It)
Apr 14
When the FDA Gives You Gene Therapy Approval, Why Does the Stock Tank? Maurice Investigates
Apr 14
When the FDA Says Yes But the Market Says Meh: A Gene Therapy Paradox
Apr 14
The Redmond Gorilla in the Room: Why Maurice Just Threw His Banana at a Valuation Chart
Apr 14
The Gorilla in the Cloud: Why Microsoft Might Be the Boring Stock Your Portfolio Actually Needs
Apr 14
When FDA Approval Makes the Stock Fall—Welcome to Gene Therapy Roulette
Apr 14
The Redmond Gorilla: Why Microsoft’s Valuation Finally Makes Sense
Apr 14
When the Market Throws a Banana Peel: Why Rocket Pharmaceuticals Just Got Interesting
Previous Page
Next Page
Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
To find out more, including how to control cookies, see here:
Cookie Policy
Subscribe
Subscribed
Trained Market Monkey
Sign me up
Already have a WordPress.com account?
Log in now.
Trained Market Monkey
Subscribe
Subscribed
Sign up
Log in
Report this content
View site in Reader
Manage subscriptions
Collapse this bar
Trained Market Monkey 